Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Gram-Negative Infections | Unmet Need | HABP/VABP Gram-Negative Infections | US/EU | 2019
MARKET OUTLOOK Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) are among the most common and serious infections in the hospital setting. HABP/…
Unipolar Depression | Access and Reimbursement | Major Depressive Disorder | US | 2019
Numerous drugs from multiple drug classes are used as monotherapies and/or adjunctive therapies for the treatment of major depressive disorder (MDD). The MDD treatment armamentarium is becoming…
Ovarian Cancer – Access & Reimbursement – Access and Reimbursement – Ovarian Cancer (EU)
Market OutlookTargeted therapies are changing the treatment paradigm for ovarian cancer in the top 5 European markets (France, Germany, Italy, Spain, UK). Roche’s Avastin and small-molecule PARP…